If you have ever had hepatitis b virus infection the hepatitis b virus could become active again during or after treatment of hepatitis c virus with sovaldi hepatitis b virus becoming active again called reactivation may cause serious liver problems including liver failure and death. China food and drug administration approves gileads sovaldir sofosbuvir for treatment of chronic hepatitis c virus infection the information in this section is intended for visitors outside the united states with approximately 10 million people infected hcv genotypes 1 2 3 and 6 account for more than 96 percent of all cases . Hepatitis c caused by various genotypes of the hepatitis c virus hcv currently infects more than 170 million people around the world the infection may lead to chronic hepatitis decompensated cirrhosis and hepatocellular carcinoma causing as many as 350000 deaths per year the majority of the cases are caused by hcv genotypes 1 70 . This infection of the liver is caused by the hepatitis c virus about 39 million people in the us have the disease but it causes few symptoms so most of them dont know there are many forms . Whilst the huge profits were great news for gilead and its shareholders the exorbitant price was bad news for most of the more than 100 million people around the world with hepatitis c because the price put sovaldi beyond the reach of most people even in wealthy countries like the usa however it was not all smooth sailing for gilead
How it works:
1. Register Trial Account.
2. Download The Books as you like ( Personal use )